Serious Adverse Events with Bevacizumab or Ranibizumab for Age-related Macular Degeneration: Meta-analysis of Individual Patient Data.
Serious Adverse Events with Bevacizumab or Ranibizumab for Age-related Macular Degeneration: Meta-analysis of Individual Patient Data.
复制标题
贝伐珠单抗或雷珠单抗治疗年龄相关性黄斑变性的严重不良事件：个体患者数据的荟萃分析。
DOI：
10.1016/j.oret.2016.12.015
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Bevacizumab-RanibizumabInternationalTrialsGroup
中科院分区：
文献类型：
--
作者：
Bevacizumab-RanibizumabInternationalTrialsGroup
